Physician profile
Michael Caudy
NPI 1275502213
$503.93
in general payments reported to CMS, 2019-2025
14 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $89.11 · 2021: $36.09 · 2022: $17.89 · 2023: $49.32 · 2024: $15.64 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $91.82 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $64.75 | 2019-2025 | |
| Abbvie INC. | $53.95 | 2020-2025 | |
| Glaxosmithkline, LLC. | $52.65 | 2020-2023 | Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $45.69 | 2020-2025 | Farxiga, Airsupra |
| Sunovion Pharmaceuticals INC. | $34.07 | 2019-2020 | |
| Novo Nordisk INC | $32.24 | 2025 | Wegovy, Ozempic |
| Abbott Laboratories | $23.39 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.34 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.28 | 2019 | |
| Allergan, INC. | $17.91 | 2020 | |
| Verrica Pharmaceuticals INC. | $15.64 | 2024 | Ycanth |
| Astellas Pharma US INC | $12.93 | 2019 | |
| Horizon Therapeutics Plc | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Caudy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.